1. Home
  2. IVVD vs HIO Comparison

IVVD vs HIO Comparison

Compare IVVD & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • HIO
  • Stock Information
  • Founded
  • IVVD 2020
  • HIO 1993
  • Country
  • IVVD United States
  • HIO United States
  • Employees
  • IVVD N/A
  • HIO N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • HIO Finance/Investors Services
  • Sector
  • IVVD Health Care
  • HIO Finance
  • Exchange
  • IVVD Nasdaq
  • HIO Nasdaq
  • Market Cap
  • IVVD 412.6M
  • HIO 368.0M
  • IPO Year
  • IVVD 2021
  • HIO N/A
  • Fundamental
  • Price
  • IVVD $2.57
  • HIO $3.72
  • Analyst Decision
  • IVVD Strong Buy
  • HIO
  • Analyst Count
  • IVVD 5
  • HIO 0
  • Target Price
  • IVVD $6.11
  • HIO N/A
  • AVG Volume (30 Days)
  • IVVD 11.9M
  • HIO 305.3K
  • Earning Date
  • IVVD 11-06-2025
  • HIO 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • HIO 10.33%
  • EPS Growth
  • IVVD N/A
  • HIO N/A
  • EPS
  • IVVD N/A
  • HIO N/A
  • Revenue
  • IVVD $50,039,000.00
  • HIO N/A
  • Revenue This Year
  • IVVD $102.11
  • HIO N/A
  • Revenue Next Year
  • IVVD $151.51
  • HIO N/A
  • P/E Ratio
  • IVVD N/A
  • HIO N/A
  • Revenue Growth
  • IVVD 332.71
  • HIO N/A
  • 52 Week Low
  • IVVD $0.35
  • HIO $3.52
  • 52 Week High
  • IVVD $3.07
  • HIO $4.03
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 64.50
  • HIO 34.00
  • Support Level
  • IVVD $2.38
  • HIO $3.75
  • Resistance Level
  • IVVD $2.70
  • HIO $3.88
  • Average True Range (ATR)
  • IVVD 0.25
  • HIO 0.03
  • MACD
  • IVVD 0.07
  • HIO -0.01
  • Stochastic Oscillator
  • IVVD 69.01
  • HIO 25.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: